Skip to content
Screener

Total Equity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$84.97B+8.3%
Perrigo Company logo
Perrigo CompanyPRGO
$2.52B-43.7%
HRO
HarrowHROW
$28.71M-49.1%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$2.06B-74.0%
Cencora logo
CencoraCOR
$3.05B+54.1%
Organon logo
OrganonOGN
$903M+66.6%

Other financials

Income statement

See full
Revenue$265.7M+6.5%
Gross profit$136.2M-3.0%
Operating income$52.5M-26.8%
Net income$29.2M-38.5%
EPS (diluted)$0.61-35.8%

Balance sheet

See full
Cash & equivalents$89.1M-36.1%
Total debt$2.1B+97.4%
Total assets$4.6B+33.1%

Cash flow

See full
Operating cash flow$70.8M-10.4%
CapEx$3.7M+342%
Free cash flow$67.1M-14.2%

Valuation

See full
Market cap$2.58B-30.3%
Enterprise value$4.55B-1.2%
P/E15×-2.4×
P/S2.3×-1.0×

Profitability

See full
Gross margin53.5%-2.6pp
Operating margin26.3%-3.8pp
Net margin15.6%-3.4pp
FCF margin21.3%-2.6pp

Returns & leverage

See full
Return on equity9.1%-2.9pp
Debt / equity1.1×+0.5×
Current ratio3.2×-1.2×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: Prestige Consumer Healthcare’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:15 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001295947-26-000042
(In thousands)June 30, 2026March 31, 2026
Authorized - 250,000 shares
Issued - 56,312 shares at June 30, 2026 and 56,211 shares at March 31, 2026563562
Additional paid-in capital612,513608,520
Treasury stock, at cost - 8,940 shares at June 30, 2026 and 8,892 shares at March 31, 2026(441,962)(439,301)
Accumulated other comprehensive loss, net of tax(29,678)(28,368)
Retained earnings1,775,2801,746,103
Total Stockholders' Equity1,916,7161,887,516
Total Liabilities and Stockholders' Equity$4,568,573$3,494,313

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Prestige Consumer Healthcare's total equity?
Prestige Consumer Healthcare (PBH) reported total equity of $1.92B in Q2 2026.
How has Prestige Consumer Healthcare's total equity changed year-over-year?
Prestige Consumer Healthcare's total equity increased by 3.3% year-over-year, from $1.86B to $1.92B.
What is the long-term trend for Prestige Consumer Healthcare's total equity?
Over 5 years (2021 to 2026), Prestige Consumer Healthcare's total equity has grown at a 6.8% compound annual growth rate (CAGR), from $1.36B to $1.89B.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ask your AI about Prestige Consumer Healthcare's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude